Thursday, March 13, 2014 | 8:00 AM - 7:00 PM
Keynote Speaker: Kelly Tappenden (University of Illinois)
Speakers: Marian de van der Schueren (VU University Medical Center, Amsterdam), Marinos Elia (University of Southampton), Leah Gramlich (Alberta Health Services North), Michael Johnson (Bayada Home Healthcare), Su Lin Lim (National University Hospital, Singapore), Hélène Payette (Université de Sherbrooke), Tomas Philipson (University of Chicago), Carla Prado (Florida State University)
The conference will focus on malnutrition's clinical and economic impacts of prevention across the continuum of care; new approaches and interventions to integrated care; and, a health systems approach to delivery of nutrition interventions.
March 15 - 17, 2014 | Qatar
Featuring: Huda Akil (University of Michigan), Karl Deisseroth (Stanford University)
Join global experts in clinical neuroscience in Doha, Qatar, for a 2.5 day, two-track conference that will feature recent advances in the understanding and treatment of mood disorders, stroke, and traumatic brain injury.
Thursday, March 20, 2014 | 6:00 PM - 8:30 PM
Speaker: Sean F. Brady (The Rockefeller University), Steven Edgar (MIT), Justin Nodwell (University of Toronto), Kang Zhou (MIT)
Secondary metabolites or idiolites play many roles in biological systems, including communication, defense and signaling. This symposium takes a systems biology approach to explore their biological effects and potential benefits for human health.
Monday, March 24, 2014 | 8:00 AM - 5:00 PM
Speakers: David Alland (Rutgers New Jersey Medical School), Stephanie Boisson-Dupuis (The Rockefeller University), Andrea M. Cooper (Trudeau Institute), Jerrold J. Ellner (Boston Medical Center), Daniel E. Everitt (TB Alliance), Michael S. Glickman (Memorial Sloan-Kettering Cancer Center), Kathleen A. McDonough (Wadsworth Center ), Steven A. Porcelli (Albert Einstein College of Medicine), Kyu Rhee (Weill Cornell Medical College), G. Marcela Rodriguez (Rutgers New Jersey Medical School), Padmini Salgame (Rutgers New Jersey Medical School), Marie Samanovic (NYU Langone Medical Center), Jessica C. Seeliger (Stony Brook University)
TB is a curable infection that should be a disease of the past, yet a third of the world's population remains affected. Join us on World TB Day to explore scientific insights towards novel diagnostics, therapeutics and vaccine-related tools.
Tuesday, March 25, 2014 | 12:00 PM - 4:00 PM
Speakers: Rolf Brekken (UT Southwestern), Jessica S. Donington (NYU Langone Medical Center), Balazs Halmos (Columbia University Medical Center), Roy S. Herbst (Yale School of Medicine), Suresh S. Ramalingam (Emory University)
Recent treatment advances may improve lung cancer patient survival rates, as understanding genetic heterogeneity can improve trial patient selection. Hear updates on common mutations, intraoperative chemotherapy, and insights from clinical trials.
Tuesday, February 18, 2014 | 8:30 AM - 4:30 PM
Speakers: John DiPersio (Washington University School of Medicine), William R. Drobyski (Medical College of Wisconsin), James Ferrara (University of Michigan), David L. Porter, MD, University of Pennsylvania Medical Center, Robert J. Soiffer (Dana-Farber Cancer Institute), Megan Sykes (Columbia University), Marcel RM van den Brink (Memorial Sloan Kettering Cancer Center)
Mechanisms that cause graft-versus-host disease (GvHD), a major cause of mortality after stem cell transplants, must be inhibited while preserving the graft-versus-tumor (GvT) response. Explore recent advances in separating GvHD from GvT effects.
Wednesday, February 5, 2014 | 7:00 PM - 8:30 PM
Featuring: Allan Kellehear, Jeffrey J. Kripal, and Lani Leary
Moderator: Steve Paulson
How do we cope with the inevitability of our mortality? Experts in psychology, philosophy and sociology come together to share a multicultural perspective on death, dying, and what lies beyond.
Monday, February 3, 2014 | 1:30 PM - 4:30 PM
Speakers: Uttiya Basu (Columbia University), Eric J. Brown (University of Pennsylvania), Samuel F. Bunting (Rutgers University), Robert P. Fisher (Icahn School of Medicine at Mount Sinai), Sarah J. Radford (McKim Lab, Waksman Institute, Rutgers University), Veronica Rodriguez-Bravo (Jallepalli Lab, Memorial Sloan-Kettering Cancer Center)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
Tuesday, January 28, 2014 | 8:30 AM - 4:30 PM
Speakers: Nahor Haddish-Berhane (Pfizer), Sara Hurvitz (UCLA Medical Center), Omar Kabbarah (Genentech Inc.), Peter D. Senter (Seattle Genetics, Inc.), Dhaval K. Shah (The State University of New York at Buffalo), Stacey S. Shord (Food and Drug Administration), Melissa M. Schutten (Genentech Inc.), and Puja Sapra (Pfizer), Alan Wahl (Ambrx)
Antibody-drug conjugates (ADCs) promise safer, more effective therapies than standard anti-cancer drugs. This symposium highlights linker-payload and coupling chemistries, ADC development, biomarker and patient selection, and regulatory perspectives.
Keynote Speaker: Barbara Burlingame (Food and Agriculture Organization of the United Nations)
This eBriefing looks at how to improve the protein supply chain, especially through programs designed to increase access to a high-quality diet for malnourished populations.
Edited by Annals of the New York Academy of Sciences
This Annals volume presents four scholarly reports: (1) Effects of Genetic, Processing, or Product Formulation Changes on Efficacy and Safety of Probiotics; (2) Probiotics and Prebiotics: Prospects for Public Health and Nutritional Recommendations; (3)Targeting Epigenetic Regulators for Cancer Therapy; and (4) Précis of Nutrition of Children and Women in Haiti: Analyses of Data from 1995 to 2012.
Organizers: Mandë Holford (Hunter College, CUNY; American Museum of Natural History), Steven Gross (Weill Cornell Medical College), and Jennifer Henry (The New York Academy of Sciences)
Keynote Speaker: Baldomero M. Olivera (University of Utah)
Venomous animals, including spiders, snakes, scorpions, sea snails, leeches, and others, produce millions of bioactive compounds, offering enormous potential for venom-based drug discovery.
Organizers: John E. Hambor (Boehringer-Ingelheim Pharmaceuticals) and Jennifer Henry (The New York Academy of Sciences)
Dendritic cells offer promise in the development of cancer vaccines.
Good oral hygiene helps prevent tooth decay and gum disease, but the health of your mouth may have a big impact on the rest of your body too—especially if you have diabetes.
September 10, 2010
Can we all be wise old owls? Science journalist Stephen Hall and neuroscientist Andre Fenton dissect what we call wisdom, from the neurons in our brain, to the social constructs behind it.
Neuroscientist Richard Restak thinks with the right mental exercises, our brains can be much better. Today he teams with writer Susan Orlean to talk about our brainy potential.
With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.
March 2, 2010
Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.
February 23, 2010
Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
April 28, 2009
Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.